Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients-Reference-Cited by-同舟云学术

Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

Published:2015-01-14 Issue:5 Volume:70 Page:1596-1598
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Chalhoub Hussein¹,Tunney Michael²,Elborn J. Stuart²,Vergison Anne³,Denis Olivier⁴,Plésiat Patrick⁵,Kahl Barbara C.⁶,Van Bambeke Françoise¹,Tulkens Paul M.¹

Affiliation:

1. 1 Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium

2. 2 CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, UK

3. 3 Unité des maladies infectieuses, Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium

4. 4 Laboratoire de microbiologie, Hôpital Erasme, Brussels, Belgium

5. 5 Laboratoire de bactériologie, Hôpital Jean Minjoz, Besançon, France

6. 6 Medical Microbiology, University Hospital Münster, Münster, Germany

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

https://academic.oup.com/jac/article-pdf/70/5/1596/42355117/jac_70_5_1596.pdf

Reference9 articles.

1. Cystic Fibrosis Foundation Patient Registry—2012 Annual Data Report;Cystic Fibrosis Foundation

2. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study;Llanes;J Antimicrob Chemother,2013

3. Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review;Gaspar;Eur J Clin Microbiol Infect Dis,2013

4. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides;Young;Pediatr Pulmonol,2013

5. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis;Conway;Thorax,1997

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review;Frontiers in Medicine;2023-09-04

2. The primary pharmacology of ceftazidime/avibactam: resistancein vitro;Journal of Antimicrobial Chemotherapy;2023-01-26

3. The primary pharmacology of ceftazidime/avibactam: in vitro translational biology;Journal of Antimicrobial Chemotherapy;2022-06-04

4. In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis;Diagnostic Microbiology and Infectious Disease;2021-02

5. Epidemiology and Mechanisms of Ceftazidime–Avibactam Resistance in Gram-Negative Bacteria;Engineering;2021-01